A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer

BACKGROUND: There is an obvious correlation between ulcerative colitis and colorectal cancer, and the risk of colorectal cancer in patients with ulcerative colitis is increasing. Therefore, the combination therapy of anti-inflammatory and anti-tumor drugs may show promising to inhibit colon cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lin, Lin, Yan, Zhang, Zijun, Yang, Ruisheng, Bai, Xiaosheng, Liu, Zhongbing, Luo, Zhongling, Zhou, Meiling, Zhong, Zhirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524854/
https://www.ncbi.nlm.nih.gov/pubmed/34666761
http://dx.doi.org/10.1186/s12951-021-01064-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524854/
https://www.ncbi.nlm.nih.gov/pubmed/34666761
http://dx.doi.org/10.1186/s12951-021-01064-3

Ejemplares similares